In the ever-evolving landscape of European pharmaceutical mergers and acquisitions (M&A) trends, Pfizer stands out as a key player. With the pressure to offset revenue losses from the previous year, Pfizer is positioned as one of the most aggressive buyers in the pharma sector. This trend reflects the dynamic nature of the industry, where companies […]